Life Competitors

Pink Sheets . USA . 
Stock . Life Healthcare Group
LTGHY Stock  USD 2.88  0.06  2.04%   
Life Healthcare Group competes with Netcare, WashTec AG, RHÖN-KLINIKUM Aktiengesellscha, Rhoen Klinikum, and Extendicare; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Care Facilities industry. Analyzing Life Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Life Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Life Healthcare Correlation with its peers.

Life Healthcare vs Arjo AB Correlation

Poor diversification

The correlation between Life Healthcare Group and ARRJF is 0.68 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Life Healthcare Group and ARRJF in the same portfolio, assuming nothing else is changed.

Moving against Life Pink Sheet

  0.67UHS Universal Health ServicesPairCorr
  0.51JDHIF JD Health InternationalPairCorr
  0.51THC Tenet HealthcarePairCorr
  0.46GRLF Green Leaf InnovationsPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.222.885.54
Details
Intrinsic
Valuation
LowRealHigh
0.122.324.98
Details
Naive
Forecast
LowNextHigh
0.353.015.67
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.632.792.95
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Life Healthcare. Your research has to be compared to or analyzed against Life Healthcare's peers to derive any actionable benefits. When done correctly, Life Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Life Healthcare Group.

Life Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Life Healthcare and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Life and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Life Healthcare Group does not affect the price movement of the other competitor.

High positive correlations

GNMLF
+ 0.95
RAFLF
ARRJF
+ 0.84
RKAGY
SAFLY
+ 0.73
EXETF
EXETF
+ 0.62
RKAGY
RAFLF
+ 0.61
WHTCF
ARRJF
+ 0.59
EXETF
  

High negative correlations

RHKJF
- 1.0
NWKHY
GNMLF
- 0.92
EXETF
RAFLF
- 0.89
EXETF
SAFLY
- 0.89
WHTCF
EXETF
- 0.7
WHTCF
GNMLF
- 0.69
RKAGY

Risk-Adjusted Indicators

There is a big difference between Life Pink Sheet performing well and Life Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Life Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NWKHY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
WHTCF  2.03 (0.28) 0.00 (0.16) 0.00 
 0.00 
 4.07 
(4.27)
 18.01 
RHKJF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
RKAGY  0.09  0.04  0.00 (0.59) 0.00 
 0.00 
 0.00 
 0.00 
 3.12 
EXETF  1.35  0.63  0.38  4.60  0.66 
(1.79)
 3.67 
(1.85)
 16.28 
PHCI  0.85 (0.06) 0.00  0.23  0.00 
 0.00 
 1.88 
(3.09)
 17.31 
SAFLY  0.54  0.25  0.00  1.28  0.00 
 0.00 
 0.00 
 0.00 
 17.99 
RAFLF  0.30 (0.14) 0.00  0.57  0.00 
 0.00 
 0.00 
 0.00 
 10.00 
GNMLF  0.79 (0.31) 0.00  2.51  0.00 
 0.00 
 0.00 
 0.00 
 14.69 
ARRJF  0.20  0.09  0.00  3.55  0.00 
 0.00 
 0.00 
 0.00 
 2.45 

Life Healthcare Competitive Analysis

The better you understand Life Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Life Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Life Healthcare's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
LTGHY NWKHY WHTCF RHKJF RKAGY EXETF PHCI SAFLY RAFLF GNMLF
 2.04 
 2.88 
Life
 0.00 
 7.17 
Netcare
 2.27 
 3.01 
WashTec
 0.00 
 15.30 
RHÖN-KLINIKUM
 0.00 
 7.60 
Rhoen
 1.04 
 16.50 
Extendicare
 0.27 
 7.50 
Panamera
 0.00 
 4.00 
Safilo
 0.00 
 0.72 
Raffles
 0.00 
 1.14 
Genomma
Market Volatility
(90 Days Market Risk)
Unstable
Very steady
Relatively risky
Very steady
Very steady
Not too volatile
Somewhat reliable
Moderately volatile
Very risky
Very steady
Market Performance
(90 Days Performance)
Weak
Weakest
Weakest
Weakest
Fair
Solid
Weakest
Fair
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Fair
Hazard
Small
Low
Low
Low
High
Low
Low
Hazard
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Hold
Cautious Hold
Strong Hold
Cautious Hold
Strong Buy
Strong Sell
Buy
Strong Sell
Not Rated
Current Ratio
0.61
1.01
1.14
2.31
2.31
1.09
0.13
1.82
1.07
1.67
Net Asset
42.24 B
26.27 B
1.26 B
1.67 B
1.67 B
900.32 M
10
937.77 M
1.55 B
21.54 B
Profit Margin
0.0539
0.0468
-0.0539
0.0183
0.0183
0.0532
-0.82
0.0505
0.14
0.081
EBITDA
3.24 B
3.56 B
21 M
101.2 M
98.83 M
79.64 M
(90.75 K)
101.96 M
161.27 M
2.84 B
Operating Margin
0.0944
0.1
0.0561
0.0187
0.0187
0.12
-0.78
0.0621
0.19
0.2
Current Valuation
2.06 B
1.66 B
716.7 M
928.19 M
928.19 M
556.43 M
78.05 M
782.28 M
1.82 B
1.09 B
Price To Book
1.27
1.76
0.95
0.8
0.68
4.28
N/A
1.71
2.25
1.38
Current Asset
3.1 B
N/A
110 M
583 M
N/A
N/A
N/A
674 M
212 M
N/A
Retained Earnings
N/A
N/A
14 M
373 M
N/A
N/A
N/A
84 M
318 M
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
6.6
N/A
N/A
N/A
N/A
Beta
0.31
0.26
1.39
0.0421
0.0421
1.2
1.47
1.38
0.61
0.53
Number Of Employees
45
32
1.51 K
18.15 K
18.15 K
31
3
4.46 K
2.7 K
2.3 K
Shares Outstanding
360.93 M
133.82 M
228.17 M
66.94 M
133.88 M
83.94 M
33.21 M
206.79 M
1.85 B
1 B
Cash Flow From Operations
4.23 B
2.61 B
22.27 M
97.5 M
97.5 M
63.42 M
(99.36 K)
17.3 M
160.11 M
1.47 B
Annual Yield
0.0244
0.0553
N/A
0.0177
0.0147
0.0721
N/A
0.18
0.0153
0.0472
Total Debt
10.33 B
5.26 B
290.6 M
148.56 M
148.56 M
463.27 M
28.95 K
131.8 M
77.91 M
3.83 B
Return On Equity
0.0878
0.0975
-0.0104
0.0265
0.0265
0.0018
N/A
0.16
0.11
0.13
Z Score
N/A
N/A
1.2
4.2
4.2
1.0
N/A
4.0
14.4
N/A
Return On Asset
0.0404
0.0539
0.0149
0.0114
0.0114
0.11
-3.23
0.0412
0.0624
0.0921
Book Value Per Share
51.94
76.56
3.09
17.15
8.58
1.49
-0.001
1.93
0.51
10.98
Current Liabilities
4.59 B
N/A
108 M
327 M
N/A
N/A
N/A
378 M
180 M
N/A
Total Asset
42.24 B
26.27 B
1.26 B
1.67 B
1.67 B
900.32 M
10
937.77 M
1.55 B
21.54 B
Debt To Equity
0.65
1.02
0.48
0.13
0.13
2.85
N/A
0.53
0.18
0.51
Last Dividend Paid
0.4
0.5
N/A
N/A
N/A
0.48
N/A
N/A
0.018
0.38
Shares Owned By Institutions
N/A
N/A
5.16
0.7
N/A
17.61
N/A
N/A
15.91
29.1
Market Capitalization
1.36 B
1.23 B
650.75 M
1.06 B
1.09 B
419.69 M
20.76 M
662.67 M
1.92 B
973.77 M
Price To Earning
18.63
43.42
17.43
622.92
540.83
500.0
N/A
48.33
31.4
11.09
Price To Sales
0.0477
0.0528
0.89
0.66
0.66
0.32
4587.48
0.64
2.49
0.0526
Net Income
1.53 B
1.01 B
(43.79 M)
28.3 M
28.3 M
11.5 M
(95.35 K)
21.27 M
84.17 M
1.31 B
Earnings Per Share
0.23
0.4
-0.17
0.47
0.23
0.01
-0.003
0.15
0.04
0.07
Shares Owned By Insiders
N/A
N/A
9.72
92.28
N/A
13.15
87.98
N/A
55.3
29.0
Revenue
28.21 B
21.64 B
302.32 M
1.4 B
1.4 B
1.22 B
41.67 K
969.58 M
723.79 M
15.49 B
Working Capital
(1.49 B)
N/A
2 M
256 M
N/A
N/A
N/A
296 M
32 M
N/A
Cash And Equivalents
1.15 B
1.39 B
57.12 M
367.94 M
367.94 M
174.61 M
4.18 K
99 M
289.07 M
1.3 B
Cash Per Share
3.16
10.4
0.25
5.6
2.8
2.08
N/A
0.48
0.16
1.3
Gross Profit
8.36 B
10.55 B
153.69 M
182.63 M
182.63 M
283.88 M
3.45 K
512.62 M
193.55 M
9.56 B
Day Typical Price
2.85
7.17
3.02
15.3
7.6
16.49
7.5
4.0
0.72
1.14
Accumulation Distribution
0.0278
N/A
7.0
N/A
N/A
1.08
N/A
N/A
N/A
N/A
Market Facilitation Index
0.08
N/A
0.0
N/A
N/A
1.0E-4
N/A
N/A
N/A
N/A
Daily Balance Of Power
(0.75)
0.0
(3.50)
0.0
0.0
4.25
0
0.0
0.0
0.0
Period Momentum Indicator
(0.06)
N/A
(0.07)
N/A
N/A
0.17
(0.02)
N/A
N/A
N/A
Rate Of Daily Change
0.98
1.0
0.98
1.0
1.0
1.01
1.0
1.0
1.0
1.0
Day Median Price
2.84
7.17
3.02
15.3
7.6
16.48
7.5
4.0
0.72
1.14
Price Action Indicator
0.01
N/A
(0.04)
N/A
N/A
0.11
(0.01)
N/A
N/A
N/A
Relative Strength Index
55.07
N/A
45.91
N/A
100.0
68.09
37.31
100.0
N/A
22.06
Coefficient Of Variation
1587.96
N/A
(1,599)
N/A
812.4
333.38
(2,787)
812.4
(812.40)
(767.43)
Mean Deviation
1.89
N/A
2.03
N/A
0.0931
1.35
0.8515
0.537
0.2984
0.7927
Jensen Alpha
0.1545
N/A
(0.28)
N/A
0.0417
0.6311
(0.06)
0.2481
(0.14)
(0.31)
Total Risk Alpha
(0.1)
N/A
(0.48)
N/A
1.0E-4
0.4312
(0.31)
0.0485
(0.28)
(0.55)
Sortino Ratio
0.0356
N/A
N/A
N/A
N/A
0.3761
N/A
N/A
N/A
N/A
Downside Variance
5.64
N/A
N/A
N/A
N/A
2.3
N/A
N/A
N/A
N/A
Standard Deviation
2.63
N/A
2.96
N/A
0.3841
2.17
2.24
2.21
1.23
2.39
Kurtosis
3.62
N/A
2.98
N/A
66.0
14.61
13.26
66.0
66.0
28.83
Potential Upside
4.31
N/A
4.07
N/A
N/A
3.67
1.88
N/A
N/A
N/A
Treynor Ratio
10.44
N/A
(0.16)
N/A
(0.59)
4.6
0.2319
1.28
0.5671
2.51
Maximum Drawdown
14.6
N/A
18.01
N/A
3.12
16.28
17.31
17.99
10.0
14.69
Variance
6.91
N/A
8.77
N/A
0.1476
4.71
5.04
4.91
1.52
5.73
Market Risk Adjusted Performance
10.45
N/A
(0.15)
N/A
(0.58)
4.61
0.2419
1.29
0.5771
2.52
Risk Adjusted Performance
0.0534
N/A
(0.04)
N/A
0.0812
0.2267
(0.02)
0.097
(0.09)
(0.09)
Skewness
0.7347
N/A
0.3992
N/A
8.12
2.73
0.3454
8.12
(8.12)
(5.24)
Semi Deviation
2.1
N/A
N/A
N/A
N/A
0.6615
N/A
N/A
N/A
N/A
Information Ratio
0.0322
N/A
(0.09)
N/A
(0.09)
0.2627
(0.07)
0.0865
(0.19)
(0.16)
Value At Risk
(3.10)
N/A
(4.27)
N/A
N/A
(1.85)
(3.09)
N/A
N/A
N/A
Expected Short fall
(2.40)
N/A
N/A
N/A
N/A
(1.79)
N/A
N/A
N/A
N/A
Downside Deviation
2.38
N/A
N/A
N/A
N/A
1.52
N/A
N/A
N/A
N/A
Semi Variance
4.41
N/A
N/A
N/A
N/A
0.4376
N/A
N/A
N/A
N/A

Life Healthcare Competition Performance Charts

Five steps to successful analysis of Life Healthcare Competition

Life Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Life Healthcare Group in relation to its competition. Life Healthcare's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Life Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Life Healthcare's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Life Healthcare Group, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Life Healthcare position

In addition to having Life Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corona Opportunity Thematic Idea Now

Corona Opportunity
Corona Opportunity Theme
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Life Pink Sheet Analysis

When running Life Healthcare's price analysis, check to measure Life Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Healthcare is operating at the current time. Most of Life Healthcare's value examination focuses on studying past and present price action to predict the probability of Life Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Healthcare's price. Additionally, you may evaluate how the addition of Life Healthcare to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY